Skip to content
Friday 4 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,831.09
0.00%
DAX
26,046.40
+0.17%
CAC 40
8,278.77
-0.09%
STOXX 50
6,392.93
+0.16%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 27 April 2011 7:24 pm  |  Updated:  Friday 31 May 2019 6:58 pm

Bernanke message cheers US markets

By: KCS-content

Add as a preferred source on Google

THE Nasdaq jumped to a 10-year high as US stocks rallied yesterday after Fed Chairman Ben Bernanke’s first-ever press conference did nothing to short-circuit investors’ optimistic outlook on the economy.

All three major US stock indexes extended gains after comments from Bernanke at his press conference, where he reiterated the Fed’s stance that inflation was a transitory problem related largely to commodity price pressures.

The Nasdaq Composite Index closed at 2,869.88, the highest close for the index since 12 December, 2000. Among the day’s leading gainers were retailers and biotechnology names.

The Russell 2000 Index hit an all-time closing high of 858.31 as investors kept buying small-caps, a sector associated with a strong outlook for economic growth.

Tom Sowanick, chief investment officer of OmniVest in Princeton, said the Federal Reserve is “inviting asset inflation” as reflected in the price action in the equities market.

The Fed’s policy-setting Federal Open Market Committee said in a statement it intends to complete its $600bn ( ) bond buying programme in June as scheduled.

At the news conference, Bernanke said there was “a bit less momentum in the economy” and he foresaw “a relatively weak number, maybe under 2 per cent” for growth in gross domestic product in the first three months this year, indicating the Fed is likely to maintain its accommodative policy despite worries about inflation.

“He handled himself real well. He didn’t fumble anything,” said Alan Valdes, director of floor trading at DME Securities in New York. “In all honesty, I would give him a B-plus. He held himself up well. He didn’t trip over any questions.”

Biotech stocks helped boost the Nasdaq, as Regeneron Pharmaceuticals surged 28.6 per cent to $67.05 after its experimental cancer drug, Zaltrap, being developed with Sanofi-Aventis, extended survival in patients in a late-stage trial.

The Dow Jones industrial average gained 95.59 points, or 0.76 per cent, to 12,690.96. The Standard & Poor’s 500 Index rose 8.42 points, or 0.62 per cent, to 1,355.66. The Nasdaq Composite Index climbed 22.34 points, or 0.78 per cent, to 2,869.88.

General Electric rose 2.7 per cent to $20.65 after its finance chief said GE’s profit growth over the next few years will be the fastest it had seen in a decade. Boeing, Whirlpool and WellPoint also moved higher after topping analysts’ expectations.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Money

Related Topics

  • NULL

Trending Articles

  • Victoria Beckham owed £350,000 by Harvey Nichols

  • Jim O’Neill: Capital gains tax hike ‘looms’ as top option for Burnham

  • Vodafone and Deliveroo look to patch up Reform ties after Yusuf prison threats

  • M&G: FTSE 100 giant hits out at Rayner’s ground rent cap as it suffers loss

  • Labour calls for Mayor to explore London Stadium sale to West Ham

More from Morning Wire

  • As it happened: FTSE 100 falls but Nasdaq soars after Nvidia sales boom

    FTSE 100 Live
    Smiling man with gray hair and glasses in a dark suit and blue tie, speaking at an event.
  • Silence Therapeutics to Participate in Three September Investor Conferences

    Business Wire
  • Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera

    Business Wire
  • Lattice to Showcase Industrial FPGA Innovations at FPGAWorld Conference 2026

    Business Wire
  • Tracker funds are turning 50 – will they make it to 100?

    Markets
    John C. Bogle, Vanguard founder, speaking at a business event, wearing a suit and tie
  • Silence Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs

    Business Wire
  • Interactive Brokers Adds Access to the Bucharest Stock Exchange, Offering Access to One of Europe’s Strongest-Performing Markets of 2025

    Business Wire
  • ReNew Announces Results for the First Quarter for Fiscal Year 2027 (Q1 FY27), Ended June 30, 2026

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook